Advanced Search

Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2003 April;69(4) > Minerva Anestesiologica 2003 April;69(4):302-7



A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care

Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036

Frequency: Monthly

ISSN 0375-9393

Online ISSN 1827-1596


Minerva Anestesiologica 2003 April;69(4):302-7

SMART 2003 - Milan, may 28-30 


Infection prevention and control in intravascular devices

Colombo D., Russolillo C.

Servizio di Anestesia e Rianimazione, Azienda Ospedaliera Luigi Sacco, Polo Universitario, Milano, Italia

Intravascular devices (IVD) are indispensable in the care of the critical patient; even so, their use can be complicated by infection, which is generally associated with longer hospital stay and ensuing higher hospital costs. It is therefore imperative that guidelines are applied that constitute a basis of information upon which the individual facility can develop its own strategy. The strategy can be outlined under the following points: a) staff training, b) surveillance of IVD-associated infections, c) hand washing, d) barrier measures during catheter introduction and management, e) insertion site management and medication systems for the insertion site, f) choice and replacement of the IVD, g) replacement of intravenous administration devices and liquids, h) antimicrobial prophylaxis.
In the management of central venous catheters (CVC), recommendations call for: 1) the use of a single lumen CVC, unless multiple accesses are needed; 2) the peripheral placement of CVCs, both in the use of tunneled catheters and/or implantable vascular devices in patients over 4 years of age in which long-term vascular access (> 30 days) is planned; 3) the use of completely implantable devices in pediatric patients less than 4 years of age requiring long-term vascular access; 4) the use of the subclavian artery as the site of CVC insertion unless clinically contraindicated (e.g. coagulopathy, anatomic alterations); 5) the application of barrier precautions during CVC introduction and in the management of the catheter and the insertion site.

language: Italian


top of page